| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 88 companies in the Health Care Providers & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2025 | ALHC Alignment Healthcare, Inc. | Kim Hyong | Chief Medical Officer | Sell | 21,020 | $15.65 | $328,970.73 | -2.0% | +0.5% | +20.9% | |
| Mar 6, 2025 | ALHC Alignment Healthcare, Inc. | Joyce Christopher J46 | Chief Legal And Admin. Officer | Sell | 35,871 | $15.57 | $558,441.63 | -4.4% | +0.5% | +20.9% | |
| Mar 5, 2025 | LH Labcorp Holdings Inc. | Anderson Kerrii B50 | Director | Sell | 500 | $255.63 | $127,817.35 | -3.7% | -1.5% | +8.5% | |
| Mar 5, 2025 | DGX Quest Diagnostics Inc | Doherty Catherine T.55 | EVP, Regional Businesses | Sell | 5,370 | $174.13 | $935,078.10 | -7.3% | +0.9% | +18.6% | |
| Mar 5, 2025 | CVS Cvs Health Corp | Clark James David51 | SVP, Cont &Chief Acct Officer | Sell | 7,513 | $66.35 | $498,487.55 | -47.2% | -3.6% | +19.3% | |
| Mar 5, 2025 | HSIC Henry Schein Inc | Kuehn Kurt P56 | Director | Sell | 2,787 | $71.55 | $199,395.92 | -15.1% | -1.2% | +12.2% | |
| Mar 5, 2025 | ELV Elevance Health, Inc. | Kendrick Charles Morgan Jr60 | EVP &President, Commercial | Sell | 3,504 | $396.30 | $1,388,635.20 | -25.7% | -4.7% | -27.9% | |
| Mar 4, 2025 | THC Tenet Healthcare Corp | Haney Cecil D | Director | Sell | 2,500 | $124.26 | $310,650.00 | -17.2% | +38.7% | +99.6% | |
| Mar 4, 2025 | DGX Quest Diagnostics Inc | Doherty Catherine T.55 | EVP, Regional Businesses | Sell | 716 | $175.79 | $125,865.64 | -1.0% | -0.3% | +19.1% | |
| Mar 4, 2025 | DGX Quest Diagnostics Inc | Prevoznik Michael E52 | SVP &General Counsel | Sell | 592 | $175.79 | $104,067.68 | -1.5% | -0.3% | +19.1% | |
| Mar 4, 2025 | ACH Accendra Health Inc/va/ | Coliseum Capital Management, LLC57 | 10% Owner | Buy | 2,893,412 | $9.47 | $27,386,158.48 | +10.7% | -34.6% | -75.3% | |
| Mar 3, 2025 | ENSG Ensign Group, Inc | Smith Barry M51 | Director | Sell | 700 | $129.15 | $90,405.00 | -2.3% | +14.0% | +64.1% | |
| Mar 3, 2025 | PETS Petmed Express Inc | Nina Capital Holdings Inc. | 10% Owner | Buy | 50,000 | $4.33 | $216,250.00 | +2.2% | -9.5% | -35.3% | |
| Mar 3, 2025 | COR Cencora, Inc. | Mauch Robert P.46 | President &CEO | Sell | 4,970 | $255.00 | $1,267,350.00 | -4.6% | +14.4% | +45.4% | |
| Mar 3, 2025 | ADUS Addus Homecare Corp | Raines Monica60 | Evp/ CCO And Quality Officer | Sell | 237 | $96.23 | $22,806.51 | -1.6% | +17.1% | +9.1% | |
| Mar 3, 2025 | MOH Molina Healthcare, Inc. | Orlando Steven J72 | Director | Sell | 1,000 | $301.33 | $301,330.00 | -5.4% | -1.8% | -52.2% | |
| Mar 3, 2025 | CHE Chemed Corp | Lee Spencer S71 | Executive Vice President | Sell | 1,326 | $592.25 | $785,323.50 | -7.0% | -3.5% | -28.3% | |
| Mar 3, 2025 | ZYXIQ Zynex Inc | Moorhead Daniel J80 | Chief Financial Officer | Sell | 10,000 | $7.15 | $71,500.00 | -49.9% | -72.0% | - | |
| Mar 3, 2025 | CI Cigna Group | Jones Nicole S54 | See Remarks | Sell | 4,904 | $308.12 | $1,511,020.48 | -14.3% | +1.1% | -8.9% | |
| Mar 3, 2025 | CI Cigna Group | Cordani David67 | Chairman &CEO | Sell | 26,527 | $308.12 | $8,173,499.24 | -17.2% | +1.1% | -8.9% | |
| Feb 28, 2025 | OPCH Option Care Health, Inc. | Bavaro Michael52 | Chief Human Resources Officer | Sell | 30,996 | $33.26 | $1,030,843.27 | -40.8% | -3.7% | -3.1% | |
| Feb 28, 2025 | MCK McKesson Corp | Tyler Brian S. | Chief Executive Officer | Sell | 8,961 | $624.00 | $5,591,664.00 | -14.8% | +11.3% | +54.2% | |
| Feb 28, 2025 | LH Labcorp Holdings Inc. | Schroeder Mark S56 | EVP, Pres Diagnostics &COO | Sell | 5,339 | $249.23 | $1,330,638.97 | -51.8% | -1.7% | +15.2% | |
| Feb 27, 2025 | COR Cencora, Inc. | Collis Steven H | Executive Chairman | Sell | 14,579 | $251.08 | $3,660,495.32 | -2.2% | +16.1% | +49.4% | |
| Feb 27, 2025 | DGX Quest Diagnostics Inc | Doherty Catherine T.55 | EVP, Regional Businesses | Sell | 824 | $172.61 | $142,230.64 | -1.2% | -0.1% | +23.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.